Navigation Links
Tumor Suppressor p53's Contradictory Regulatory System

A new study appearing in the online open-access journal PLoS Biology examines the role played by the tumor suppressor protein called p53. It has been found that any mutations of p53 play a key role in the development of many human cancers. //This particular study was carried out by Min Hu, Yigong Shi and colleagues.

To provide a bit of background, when there a cell injury, p53 triggers the activity of several stress-induced genes. In healthy cells, however, p53 levels are controlled by MDM2, a protein that degrades it. Another protein called HAUSP (herpesvirus-associated ubiquitin-specific protease) also plays a role in the regulation of p53's activity by promoting cell death. But HAUSP also plays a key role in destabilizing MDM2. It was this contradictory nature that interested the researchers. They wanted to look at the final sate of p53 after it was regulated by both MSM2 and HAUSP. Hu and his team found that both p53 and MDM2 bind on the same location on HAUSP. They also report that this was possible by conserving a “short amino acid signature" The reseraches arrived at the conclusion that p53-MDM2 pathway is regulated by HAUSP. These findings provide researchers with potential drug-screening targets. By inhibiting HAUSP and consequently MDM2, the tumor promoting mutations could be inhibited.

Main article: Hu M, Gu L, Li M, Jeffrey PD, Gu W, et al. (2006) Structural basis of competitive recognition of p53 and MDM2 by HAUSP/USP7: Implications for the regulation of the P53-MDM2 pathway. PLoS Biol 4(2): e27. LINK: dx.doi.org/10.1371/journal.pbio.0040027
'"/>




Page: 1

Related medicine news :

1. Use of Cellular Phones associated with Increased risk of Brain Tumors
2. Radiofrequency Energy Cooks Tumors Without Surgery
3. New Liver Tumor Treatment
4. Latest Tumor Classification More Informative
5. New Technique For Benign Breast Tumors
6. Another Treatment Option for Benign Tumors
7. Understanding The Origin Of Tumors
8. Outpatient Treatment Possible For Patients with Uterine Fibroid Tumors
9. Stem Cells, Tumor Cells Share Similar Properties: Scope For Treatment and Prevention?
10. Lipoma Arborescens: A Rare Tumor Of The Knee
11. Researchers Develop Mouse Model Of Brain Tumor
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/11/2016)... ... February 11, 2016 , ... From ... American Academy of Dermatology Annual Meeting at the Walter E. Washington Convention Center ... awareness for both the condition of hyperhidrosis (excessive sweating) and its treatment options. ...
(Date:2/11/2016)... ... February 11, 2016 , ... Food Labeling ... in health and wellness best practices in the past couple of decades, and ... is American Heart Month, which acts as an exceptional opportunity to revise food ...
(Date:2/11/2016)... ... ... As part of their 2015 end of year funding strategy, Colleen’s ... gifted $10,000 to University of Chicago to support ovarian cancer research being conducted by ... honored to support a promising young investigator from Dr. Lengyel’s lab at the University ...
(Date:2/10/2016)... ... 10, 2016 , ... Sherly Sulaiman, certified clinical hypnotherapist and ... sessions to help Los Angeles-area actors cope with rejection, improve their auditions, and ... as “Mindfulness for Actors and Artists,” has been featured in Daily Actor ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... care communications company offering education, research and medical media, has launched ... working in infectious diseases. , As the all-inclusive resource for infectious disease ...
Breaking Medicine News(10 mins):
(Date:2/11/2016)... 2016 North America , ... MarketsandMarkets, The global market is expected to reach USD 20,190.1 Million ... CAGR of 10.2%. --> North America , ... by MarketsandMarkets, The global market is expected to reach USD 20,190.1 ... a CAGR of 10.2%. --> According to a new ...
(Date:2/10/2016)... SINGAPORE , Feb. 11, 2016  QT Vascular ... "QT Vascular", and together with its subsidiaries, the ... its ongoing litigation with AngioScore, Inc. ("ÄngioScore") (now ... the United States ... (the "Federal Circuit") reversed an earlier district court ...
(Date:2/10/2016)... PITTSBURGH , 10 februari ... och detta pressmeddelande får inte distribueras, vare ... och inga anmälningssedlar kommer att accepteras från ... land där Erbjudandet, distribution av detta pressmeddelande ... strida mot tillämpliga lagar eller regler eller ...
Breaking Medicine Technology: